Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining on the treatment for the rest of their lives, according to a new study led ...
ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...
Around one in seven adults in the United States have chronic kidney disease (CKD), a condition in which the kidneys become damaged and can’t work as efficiently. This allows waste products to build up ...
CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today ...
Subtle abnormalities in kidney function—even within the range considered normal—may help identify people at risk of ...
Please provide your email address to receive an email when new articles are posted on . Incidence of end-stage kidney disease for those with newly diagnosed antibody-associated vasculitis was 22% at ...
A less intensive dialysis strategy is feasible for stable patients with acute kidney injury, but warrants further testing. A conservative vs conventional approach to hemodialysis may help ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...